E7050
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Solid Tumors
Conditions
Solid Tumors
Trial Timeline
Oct 1, 2009 → Jun 1, 2011
NCT ID
NCT00921869About E7050
E7050 is a phase 1 stage product being developed by Eisai for Solid Tumors. The current trial status is completed. This product is registered under clinical trial identifier NCT00921869. Target conditions include Solid Tumors.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01428141 | Phase 1 | Completed |
| NCT02533102 | Phase 1 | Completed |
| NCT00921869 | Phase 1 | Completed |
| NCT00869895 | Phase 1 | Completed |
Competing Products
20 competing products in Solid Tumors